Investigational hydronidone, when added to entecavir (Baraclude), reduced liver fibrosis for chronic hepatitis B patients, a phase II trial in China found. In an intention-to-treat analysis of 168 ...
Patients with untreated chronic hepatitis B who had metabolic comorbidities were at a higher risk for advanced liver fibrosis and were less likely to see improvement with antiviral therapy than those ...
HCV infection is the underlying cause for chronic Hepatitis C (CHC), liver cirrhosis, and liver cancer or hepatocellular carcinoma (HCC). In 2019, over 2,90,000 people died of HCV-related diseases.
Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San ...
When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...
A recent study reveals that a common household chemical could potentially triple your risk of serious liver scarring.
Microscopy image showing activated hepatic stellate cells (HSCs), indicated by red staining (left image). Inhibition of CYB1B1 reduces HSC activation (right image), which leads to reduced liver ...
Your liver is one of the most important organs of the body as it helps in detoxification, metabolism, and several other functions. The organ helps in filtering blood, producing bile, digesting fat, ...
The schematic diagram maps the involvement of specific DUBs throughout the progression of liver disease, including MASLD, liver fibrosis, hepatitis, and HCC. Arrows directed at HCC denote DUBs that ...